Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-Dose Aspirin in Postpartum Preeclampsia
NCT03667326Phase 2Recruiting
- Sponsor
- Columbia University
- Start
- Jul 2019
- Primary completion
- Jun 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of aspirin in preeclampsia, sponsored by Columbia University. Started Jul 2019; status: recruiting.
02
Drugs
aspirin
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT03667326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03667326.